Blog - Page 4541 of 5395

WednesdayMar 12, 2008 5:57 am

StockGuru Blog: More From New Profile Sports Pouch Beverage Company (SPBV)

New Machine: Perricone Juice Plant On March 10th, the Sports Pouch Beverage Company announced the arrival of another pouching machine. This machine will be placed and operated in the Perricone Juice Plant to produce the patent-pending pouch with a pull-push sports cap with Perricone 100% All Natural Juices. The company plans on introducing their brand at one of the largest Natural Food Expos in the United States mid-March this year. Perricone Juices has a concrete reputation and delivers a highly accepted line of fresh squeezed 100% all natural juice to a vast number of high-end restaurants and hotels. Production Capabilities…

WednesdayMar 12, 2008 5:51 am

StockGuru Trade Alert: Guru Profile Extreme Fitness (EXTF) Up 75% Wednesday Morning

WednesdayMar 12, 2008 5:50 am

StockGuru Trade Alert: Guru Profile Triangle Petroleum (TPLM) Up $0.09 and More than 10% Today

StockGuru Trade Alert: Guru Profile Triangle Petroleum (TPLM) Up $0.09 and More than 10% Today Today’s High So Far of $0.94 Puts TPLM Up 10.59% from Yesterday’s Close of $0.85!

WednesdayMar 12, 2008 5:48 am

StockGuru News: Tootie Pie Company January Sales Up 170%

BOERNE, TX–Mar 12, 2008 — The Tootie Pie Company, Inc., a premium baker and seller of high-quality, handmade pies, announced today that it sold in excess of 2,700 pies for the month of January, 2008. This is approximately a 170% increase over the 1,000 plus pies sold in January of 2007. “January begins one of the slowest periods of the year in the food business. Growing sales during these ‘off season’ months is an integral part of our overall sales and marketing strategy. We are very pleased with these sales gains and the way this year is taking shape,” said…

WednesdayMar 12, 2008 5:47 am

StockGuru Trade Alert: Guru Profile Delta Mining & Exploration (DMXC) Up 20% on Volume Greater than Ten-Day Average

WednesdayMar 12, 2008 5:46 am

StockGuru Trade Alert: Profile Stock Silver Falcon Mining (SFMI) Up 27% Intraday and as Much as 48% Since Monday

StockGuru Trade Alert: Profile Stock Silver Falcon Mining (SFMI) Up 27% Intraday and as Much as 48% Since Monday From Monday’s Closing Price of $0.06, Today Our Profile SFMI Has Moved to as High as $0.089 View the StockGuru Profile for SFMI: http://www.stockguru.com/profiles/sfmi/

WednesdayMar 12, 2008 5:45 am

StockGuru Trade Alert: Profile Stock China Media Group (CHMD) Up Over 18% Intraday and as Much as 72% Since Friday

StockGuru Trade Alert: Profile Stock China Media Group (CHMD) Up Over 18% Intraday and as Much as 72% Since Friday View the StockGuru Profile for CHMD: http://www.stockguru.com/profiles/chmd/

WednesdayMar 12, 2008 5:42 am

StockGuru Trade Alert: Guru Profile American Nano Silicon Technology (ANNO) Up More than 18% Wednesday Afternoon

WednesdayMar 12, 2008 5:30 am

Rudy Nutrition, Inc. (RUNU.PK) Announces Promotion through QualityStocks.net

Rudy Nutrition, Inc. will be featured in upcoming Daily Newsletters, Daily Blogs, Message Boards, and the Small Cap Daily Internet broadcasts put out by QualityStocks. QualityStocks has over 600,000+ subscribers to The Daily Stock Newsletter, which is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters and puts it all into one Free Daily Newsletter Report. Daniel Ruettiger, CEO of Rudy Nutrition, has the company focused on creating, distributing and licensing "Rudy" branded products that offer healthier alternative choices for parents, kids, athletes, and active people looking for something special. Mr. Ruettiger stated, “Rudy…

WednesdayMar 12, 2008 5:21 am

Keryx Biopharmaceuticals, Inc. (KERX) Drug Fails FDA Trial But CEO States It’s Not The End Of Keryx

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) had disappointing news on March 7, 2008. They announced that their Sulonex SUN-MICRO Phase 3 clinical trial failed to meet the primary objective of the study. This Phase 3 trial was for the treatment of diabetic nephropathy. Michael S. Weiss, the Company's Chairman and Chief Executive Officer, commented, "We are all very disappointed with the outcome of this study. While this represents the end of one chapter for Keryx, it is not the end of Keryx. Drug development is inherently risky and, accordingly, we have spent the last several years building what we believe to…

Site Search

Company Search